EDITORIAL
Published on 01 Feb 2023
Editorial: Integration of structural biology data in lead drug discovery and optimization
doi 10.3389/fmolb.2023.1145834
- 1,432 views
- 1 citation
- Frontiers in Molecular Biosciences
- Structural Biology
- Research Topics
- Integration of Structural Biology Data in Lead Drug Discovery and Optimization
Integration of Structural Biology Data in Lead Drug Discovery and Optimization
10k
Total downloads
53k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 14 Dec 2022
Crystal polymorphism in fragment-based lead discovery of ligands of the catalytic domain of UGGT, the glycoprotein folding quality control checkpoint
doi 10.3389/fmolb.2022.960248
- 1,934 views
- 2 citations
ORIGINAL RESEARCH
Published on 25 Aug 2022
A Fe2+-dependent self-inhibited state influences the druggability of human collagen lysyl hydroxylase (LH/PLOD) enzymes
doi 10.3389/fmolb.2022.876352
- 2,987 views
- 2 citations
ORIGINAL RESEARCH
Published on 04 Jul 2022
Innovative Approach for a Classic Target: Fragment Screening on Trypanothione Reductase Reveals New Opportunities for Drug Design
doi 10.3389/fmolb.2022.900882
- 2,031 views
- 5 citations
ORIGINAL RESEARCH
Published on 30 May 2022
Structural Characterization of Mycobacterium abscessus Phosphopantetheine Adenylyl Transferase Ligand Interactions: Implications for Fragment-Based Drug Design
doi 10.3389/fmolb.2022.880432
- 2,195 views
- 7 citations
ORIGINAL RESEARCH
Published on 11 May 2022
Targeting the Essential Transcription Factor HP1043 of Helicobacter pylori: A Drug Repositioning Study
doi 10.3389/fmolb.2022.887564
- 2,512 views
- 4 citations
REVIEW
Published on 14 Apr 2022
High-Throughput Native Mass Spectrometry Screening in Drug Discovery
doi 10.3389/fmolb.2022.837901
- 11,940 views
- 28 citations
PERSPECTIVE
Published on 11 Apr 2022
Experiences From Developing Software for Large X-Ray Crystallography-Driven Protein-Ligand Studies
doi 10.3389/fmolb.2022.861491
- 1,791 views
- 1 citation
ORIGINAL RESEARCH
Published on 07 Apr 2022
Structural Basis of Human Dimeric α-Amino-β-Carboxymuconate-ε-Semialdehyde Decarboxylase Inhibition With TES-1025
doi 10.3389/fmolb.2022.834700
- 2,264 views
- 4 citations
REVIEW
Published on 30 Mar 2022
Using Structure-guided Fragment-Based Drug Discovery to Target Pseudomonas aeruginosa Infections in Cystic Fibrosis
doi 10.3389/fmolb.2022.857000
- 5,304 views
- 4 citations
MINI REVIEW
Published on 30 Mar 2022
Recent Approaches to the Identification of Novel Microtubule-Targeting Agents
doi 10.3389/fmolb.2022.841777
- 5,002 views
- 21 citations
ORIGINAL RESEARCH
Published on 18 Feb 2022
Fragment-Based Drug Discovery by NMR. Where Are the Successes and Where can It Be Improved?
doi 10.3389/fmolb.2022.834453
- 8,565 views
- 24 citations
Published in
Frontiers in Molecular Biosciences
- Structural Biology
Participating Journals
Frontiers in Cell and Developmental Biology
Structural BiologyOffline
- 4.6 impact factor
- 9.7 citescore
Impact
- 53kTopic views
- 40kArticle views
- 10kArticle downloads